Zoetis · 2 months ago
Formulations Intern
Zoetis is the largest animal health company in the world, with an industry-leading veterinary medicine research and development team. We seek a talented formulation scientist to join and actively contribute to our research and development team’s efforts to develop novel veterinary therapeutics.
AgricultureBiotechnologyHealth CareMedicalPharmaceuticalVeterinary
Responsibilities
Support research and development of novel pharmaceutical drug products and vaccines, including sterile liquids, lyophilized products, oral solids, suspensions, topicals, and various other dosage forms
Execute and assist in laboratory experiments and operate equipment under supervision of senior colleagues
Learn and execute drug product formulation techniques
Perform testing on pharmaceutical drug products and vaccines
Operate freeze-drying/lyophilization equipment
Qualification
Required
Currently enrolled in or recently completed collegiate BS program in chemistry, pharmaceutics, chemical/biomedical engineering, or related field
Experience working in laboratory environment and operating common laboratory equipment
Experience authoring scientific technical documents
Effective communication skills
Experience working in matrix-like teams and collaborating with diverse scientists
Preferred
Experience or familiarity with pharmaceutical freeze-dryings / lyophilization
Company
Zoetis
Zoetis is an animal health company that advances care for animals and supports their health and wellbeing.
H1B Sponsorship
Zoetis has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (136)
2024 (80)
2023 (89)
2022 (126)
2021 (47)
2020 (63)
Funding
Current Stage
Public CompanyTotal Funding
$3.62BKey Investors
Bill & Melinda Gates Foundation
2025-12-16Post Ipo Debt· $1.75B
2025-08-11Post Ipo Debt· $1.85B
2023-03-01Grant· $15.3M
Recent News
Company data provided by crunchbase